Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 1, 1996
Neoadjuvant treatment in oesophageal cancer: the needs for future trials. The Rotterdam Esophageal Tumor Study GroupT C Kok, H W TilanusActa Oncologica (Stockholm, Sweden)|January 1, 1988
Etoposide and cisplatin in advanced esophageal cancer. A preliminary reportT C Kok, T A Splinter, J VerweijSeminars in Oncology|April 1, 1992
A phase I study of daily oral teniposide for 20 daysE F Smit, T A Splinter, T C KokAnnals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
5-fluorouracil and folinic acid in advanced adenocarcinoma of the esophagus or esophago-gastric junction area. Rotterdam Esophageal Tumor Study GroupT C Kok, A van der Gaast, T A SplinterJournal of Cancer Research and Clinical Oncology|January 1, 1989
Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. A non-randomized pilot studyT A Splinter, H Obertop, T C Kok, et al.Nederlands Tijdschrift Voor Geneeskunde|April 3, 1993
[Treatment and course of desmoid tumors in 5 patients with familial adenomatous polyposis]J H van Dam, W R Schouten, T C KokSeminars in Oncology|December 1, 1992
What is the optimal dose and duration of treatment with etoposide? I. Maximum tolerated duration of daily treatment with 50, 75, and 100 mg of oral etoposideT A Splinter, A van der Gaast, T C KokEuropean Urology|January 1, 1991
Growing teratoma syndrome successfully treated with lymphoblastoid interferonA van der Gaast, T C Kok, T A SplinterSeminars in Oncology|December 1, 1992
What is the optimal dose and duration of treatment with etoposide? II. Comparative pharmacokinetic study of three schedules: 1 x 100 mg, 2 x 50 mg, and 4 x 25 mg of oral etoposide daily for 21 daysA van der Gaast, M Vlastuin, T C Kok, et al.Seminars in Oncology|April 1, 1992
Absolute bioavailability and pharmacokinetics of oral teniposideT A Splinter, J J Holthuis, T C Kok, et al.Pageof 4